Healthcare Contract Research Outsourcing Market Size to Grow US$ 69.2 Billion By 2030

The global healthcare contract research outsourcing market size was valued at US$ 41.5  billion in 2021 and is anticipated to grow US$ 69.2  billion by 2030, registering a CAGR of 5.85%  from 2022 to 2030.

The healthcare contract research outsourcing market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the healthcare contract research outsourcing market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the healthcare contract research outsourcing report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the healthcare contract research outsourcing market have been studied and analysed across many developments.

Market Scope

 

Research Approach

The comprehensive report on the global healthcare contract research outsourcing market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global healthcare contract research outsourcing market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

• Advanced Clinical
• Albany Molecular Research, Inc.
• Charles River Laboratories International, Inc.
• Clinipace
• Clintec
• Covance Clinical Biotech
• CTI Clinical Trial & Consulting
• GVK Biosciences Private Limited
• ICON Plc
• IQVIA HOLDINGS INC.
• Jubilant Biosys Ltd.
• KCR S.A.
• Laboratory Corporation of America Holdings
• Medidata Solutions, Inc.
• Olon Ricerca Bioscience
• PAREXEL International Corp.
• Pharmaceutical Product Development, LLC.
• Pharmaron
• Pharm-Olam, LLC
• PRA Health Sciences, Inc.
• PSI CRO AG
• SGS SA
• Sygnature Discovery Limited
• Syneos Health
• SynteractHCR
• Thermo Fisher Scientific Inc.
• Worldwide Clinical Trials
• WuXi AppTec

Market Segmentations

By Type

• Drug Discovery
  • Target Validation
  • Lead Identification
  • Lead Optimization
• Pre-Clinical
• Clinical
  • Phase I Trial Services
  • Phase II Trial Services
  • Phase III Trial Services
  • Phase IV Trial Services

By Service

• Clinical Trial Services
  • Preclinical
  • Clinical
• Regulatory Services
• Clinical Data Management & Biometrics
  • Electronic Data Capture
  • Electronic Patient Recorded Outcomes
  • Others
• Medical Writing
• Pharmacovigilance
• Site Management Protocol
• Others

By Application

• Oncology/Hematology
• Cardiovascular
• Autoimmune/Inflammation
• Central nervous system (CNS)
• Dermatology
• Infectious diseases
• Diabetes
• Pain
• Other

By End Use

• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Companies
• Academic Institutes & Government Organizations

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare Contract Research Outsourcing Market 

5.1. COVID-19 Landscape: Healthcare Contract Research Outsourcing Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Contract Research Outsourcing Market, By Type

8.1. Healthcare Contract Research Outsourcing Market, by Type, 2022-2030

8.1.1. Drug Discovery

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Pre-Clinical

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Clinical

8.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare Contract Research Outsourcing Market, By Service

9.1. Healthcare Contract Research Outsourcing Market, by Service, 2022-2030

9.1.1. Clinical Trial Services

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Regulatory Services

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Clinical Data Management & Biometrics

9.1.3.1. Market Revenue and Forecast (2017-2030)

9.1.4. Medical Writing

9.1.4.1. Market Revenue and Forecast (2017-2030)

9.1.5. Pharmacovigilance

9.1.5.1. Market Revenue and Forecast (2017-2030)

9.1.6. Site Management Protocol

9.1.6.1. Market Revenue and Forecast (2017-2030)

9.1.7. Others

9.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Healthcare Contract Research Outsourcing Market, By Application 

10.1. Healthcare Contract Research Outsourcing Market, by Application, 2022-2030

10.1.1. Oncology/Hematology

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Oncology/Hematology

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Autoimmune/Inflammation

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Central nervous system (CNS)

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Dermatology

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Infectious diseases

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Diabetes

10.1.7.1. Market Revenue and Forecast (2017-2030)

10.1.8. Pain

10.1.8.1. Market Revenue and Forecast (2017-2030)

10.1.9. Other

10.1.9.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Healthcare Contract Research Outsourcing Market, By End Use 

11.1. Healthcare Contract Research Outsourcing Market, by End Use, 2022-2030

11.1.1. Pharmaceutical Companies

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Biotechnology Companies

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Medical Device Companies

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Academic Institutes & Government Organizations

11.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Healthcare Contract Research Outsourcing Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.2. Market Revenue and Forecast, by Service (2017-2030)

12.1.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.4. Market Revenue and Forecast, by End Use (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Service (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Service (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.2. Market Revenue and Forecast, by Service (2017-2030)

12.2.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Service (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Service (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Service (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Service (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.2. Market Revenue and Forecast, by Service (2017-2030)

12.3.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Service (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Service (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Service (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Service (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.2. Market Revenue and Forecast, by Service (2017-2030)

12.4.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Service (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Service (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Service (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Service (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Application (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.2. Market Revenue and Forecast, by Service (2017-2030)

12.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Service (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Service (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Application (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End Use (2017-2030)

Chapter 13. Company Profiles

13.1. Advanced Clinical

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Albany Molecular Research, Inc.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Charles River Laboratories International, Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Clinipace

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Clintec

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Covance Clinical Biotech

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. CTI Clinical Trial & Consulting

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. GVK Biosciences Private Limited

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. ICON Plc

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. IQVIA HOLDINGS INC.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global healthcare contract research outsourcing market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for healthcare contract research outsourcing are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2132

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com